VANECK VECTORS ETF TR shareholders Q2 2023

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 733 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.

VANECK VECTORS ETF TR shareholders Q2 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$22,236,23570.19%
Arctis Global LLC 2,825,786$85,084,41632.16%
Antipodean Advisors LLC 75,000$2,258,25016.02%
New Harbor Financial Group, LLC 1,709,339$51,468,19313.59%
Activest Wealth Management 210,700$14,364,8649.94%
Point72 Hong Kong Ltd 1,250,000$37,637,5009.42%
Monaco Asset Management SAM 750,000$22,582,5006.30%
New Harbor Financial Group, LLC 791,300$23,826,0436.29%
Guild Investment Management, Inc. 145,388$4,377,6366.16%
Nokomis Capital, L.L.C. 599,228$18,042,7556.08%
Slate Path Capital LP 5,455,000$164,250,0506.01%
PCG Wealth Advisors, LLC 266,228$8,016,1374.98%
Mader & Shannon Wealth Management, Inc. 239,267$7,204,3294.45%
MENLO ADVISORS LLC 223,105$6,7174.23%
CQS (US), LLC 1,160,813$34,952,0794.20%
BlueCrest Capital Management Ltd 4,070,300$122,556,7334.09%
Forest Hill Capital, LLC 279,500$8,415,7453.99%
STRATEGIC INVESTMENT MANAGEMENT, LLC 111,170$3,489,6263.81%
Cypress Capital Management LLC (WY) 112,559$3,389,1513.79%
Barry Investment Advisors, LLC 350,714$10,559,9973.57%
External links

This page lists VANECK VECTORS ETF TR's shareholders in Q2 2023. To view VANECK VECTORS ETF TR's shareholder history, click here.